LENZ Therapeutics, Inc. (LENZ) ownership: Top institutional holder: RA CAPITAL MANAGEMENT, L.P. ($38.24M). Insider activity: Net Seller (3 buys, 17 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 4178823.00 | $38.24M | 2026-03-31 |
| Alpha Wave Global, LP | 3612211.00 | $33.05M | 2026-03-31 |
| FMR LLC | 3597784.00 | $32.92M | 2026-03-31 |
| Versant Venture Management, LLC | 2656888.00 | $24.31M | 2026-03-31 |
| VANGUARD GROUP INC | 1321202.00 | $21.14M | 2025-12-31 |
| BlackRock, Inc. | 1976823.00 | $18.09M | 2026-03-31 |
| Point72 Asset Management, L.P. | 340000.00 | $15.84M | 2025-09-30 |
| Squarepoint Ops LLC | 1506499.00 | $13.78M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Buy | null | 2026-03-27 |
Back to LENZ overview · LENZ earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.